Hence, the loss of tp53 may be a facilitator for the early step of gastric tumorigenesis, which is supported by the observation that gastric organoids are deleted for tp53 to evolve toward dysplasia and then adenocarcinomas when implanted in vivo [272]. Here, TP53 is linked to adenocarcinoma.